DETECTION OF HUMAN RETROVIRUSES NLM AIDSLINE Important note: Information in this article was accurate in 1989. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


DETECTION OF HUMAN RETROVIRUSES

AIDS: Etiology, Diagnosis, Treatment, and Prevention. Second Edition. DeVita VT Jr et al, eds. Philadelphia, Lippincott, p. 137-54, 1988.. Unique Identifier : AIDSLINE ICDB/89650905
Poiesz BJ; Ehrlich GD; Papsidero LD; Sninsky JJ; SUNY Health Science Center, Syracuse, NY


Abstract: Strategies employing a variety of serologic assays to detect natural antibodies to the viral structural proteins are currently used to identify patients who have been exposed to human retroviruses and to exclude potentially infected blood products from being transfused. Although some of these techniques are suitable for mass screening for viral exposure, it is clear that they provide insufficient information for complete analyses of these retroviral infections. Methodologies suitable for retroviral detection, quantitation, isolation, and characterization are described, with emphasis on human T-cell lymphoma/leukemia virus (HTLV-I) and HIV-I because they are currently the most clinically relevant isolates. However, these methodologies apply to any human retroviruses now known or yet to be discovered. Topics discussed include the retroviral life cycle, retrovirus detection and isolation, and clinical studies using gene amplification by the polymerase chain reaction (PCR) method for detection of viruses in patients and determining the in vitro or in vivo efficacy of antiviral agents. The PCR technique depends on prior knowledge of the nucleic acid sequences to be detected, but it requires fewer infected cells and is less tedious and laborious than in situ hybridization methods. Discovery of new human retroviruses necessarily involves the laborious task of selective cell culture, virus detection for reverse transcriptase, isolation of the virus, and its ultimate purification and characterization. Once the proteins and nucleic acids of the viruses have been established, sensitive and specific techniques exist for their rapid detection and analysis in future studies. This ability should allow the performance of important clinical studies. (83 Refs)
Keywords: Acquired Immunodeficiency Syndrome/*MICROBIOLOGY AIDS-Related Complex/GENETICS DNA, Viral/GENETICS Gene Amplification Genes, Viral Human HIV-1/*GENETICS/PHYSIOLOGY HTLV-I/*GENETICS/PHYSIOLOGY HTLV-I Infections/*MICROBIOLOGY Leukemia-Lymphoma, T-Cell, Acute, HTLV-I-Associated/GENETICS Viral Proteins/GENETICS Virus Replication MONOGRAPH REVIEW REVIEW, TUTORIAL

KWDacquiredimmunodeficiencysyndrome/KWDmicrobiologyaids-relatedcomplex/geneticsdna,viral/geneticsgeneamplificationgenes,viralhumanhiv-1/KWDgenetics/physiologyhtlv-i/KWDgenetics/physiologyhtlv-iinfections/KWDmicrobiologyleukemia-lymphoma,t-cell,acute,htlv-i-associated/geneticsviralproteins/geneticsvirusreplicationmonographreviewreview,tutorial
890530
M8950681


Copyright © 1989 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1989. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1989. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .